FDA's Push For Compounding Oversight Meets Skepticism
Legal and public health experts are skeptical of the U.S. Food and Drug Administration's push for new authority over compounding pharmacies, arguing the FDA could have used its existing power to...To view the full article, register now.
Already a subscriber? Click here to view full article